Global Medical REIT price target lowered to $12 from $14 at B. Riley

B. Riley analyst Bryan Maher lowered the firm’s price target on Global Medical REIT to $12 from $14 and keeps a Buy rating on the shares. The analyst reduced estimates to reflect a slowdown in external growth, combined with higher interest expense.